The COVID-19 pandemic creates unusual circumstances and atypical needs. Fortunately, startups led by U of T Med alumni are at the ready to meet many of the new requirements.
The pandemic demands accurate forecasting. When will the next outbreak occur? And where? That’s the focus of BlueDot, which Dr. Kamran Khan (9T6) founded. BlueDot is dedicated to strengthening global readiness for dangerous epidemics.
Dr. Berry was a neurology resident in Toronto and received his fellowship as an academic registrar at the National Hospital at Queen Square in London, England, from 1960 to 1962, as did many Canadian neurologists of that era, where he studied both neurology and psychiatry.
Henry came back to Toronto to a staff neurology position at St. Michael’s Hospital from 1963 to 1998. He was Head of the St. Michael’s Hospital Division of Neurology from 1970 to 1976 and Head of the Clinical Neurophysiology Department, providing neurophysiology expertise from 1970 to 1996. A skilled clinician, he was also a scientist engaged in neurophysiology research as this field was developing. He had over 100 scientific publications and presentations to his name in a broad array of medical disciplines. With his psychiatry background he had an interest in functional disorders, and in his later years he was the terror of head injury and whiplash plaintiff lawyers across Canada as he engaged in medicolegal work, making full use of his multidisciplinary skills. He was still lecturing into his eighth decade at Osgoode Hall Law School.
In 1989, Chris Newman started her career as a staff physician in the SickKids NICU, but even prior to that, she trained there both as a resident and a fellow. Her initial clinical appointment was in the Division of Neonatology, where she quickly rose to be the NICU Clinical Director.